Brandon Capital Partners
Level 9, 278 Collins Street
Melbourne VIC 3000
Stephen is a founding partner of Brandon Capital Partners. Prior to this Stephen was a Director of Apax Partners. Before joining Apax Partners, he fulfilled roles in product development with UK biotechnology company Cantab Pharmaceuticals. Earlier, Stephen spent ten years as a research immunologist in London and California.
Stephen is a Director of; MecRx P/L, OncoRes Medical P/L and Vaxxas P/L and a former director of Elastagen P/L (sold to Allergan). Stephen has an Honours degree in Immunology and Biochemistry, a PhD in Immunology from Kings College London and an MBA, specialising in Entrepreneurship, from Imperial College London. Stephen is a Graduate of the Australian Institute of Company Directors.